Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Top Cited Papers
- 29 November 2012
- Vol. 30, F88-F99
- https://doi.org/10.1016/j.vaccine.2012.06.095
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceThe Lancet Oncology, 2011
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialThe Lancet Oncology, 2009
- A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural ChinaThe Lancet Oncology, 2008
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsAmerican Journal of Obstetrics and Gynecology, 2007
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural IndiaInternational Journal of Cancer, 2005